Evidence map›Paper›PMID 40230675›Full record

ReviewJournal of the Society for Cardiovascular Angiography & Interventions2025

Profiling of Cardiogenic Shock: Incorporating Machine Learning Into Bedside Management.

Elric Zweck, Song Li, Daniel Burkhoff, Navin K Kapur

Abstract readReview
In one paragraph

Review in Journal of the Society for Cardiovascular Angiography & Interventions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Acute Myocardial Infarction and Stage E Shock: Insights From the RECOVER III Study.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elric ZweckThe CardioVascular Center, Tufts Medical Center, Boston, Massachusetts.
Song LiMedical City Healthcare, Dallas, Texas.
Daniel BurkhoffCardiovascular Research Foundation, New York, New York.
Navin K KapurThe CardioVascular Center, Tufts Medical Center, Boston, Massachusetts.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiogenic shock (CS) is a complex clinical syndrome with various etiologies and clinical presentations. Despite advances in therapeutic options, mortality remains high, and clinical trials in the field are complicated in part by the heterogeneity of CS patients. More individualized targeted therapeutic approaches might improve outcomes in CS, but their implementation remains challenging. The present review discusses current and emerging machine learning-based approaches, including unsupervised and supervised learning methods that use real-world clinical data to individualize therapeutic strategies for CS patients. We will discuss the rationale for each approach, potential advantages and disadvantages, and how these strategies can inform clinical trial design and management decisions.

Indexed as

cardiogenic shockheart failuremachine learningmyocardial infarctionphenotyping

Identifiers

PMID40230675
PMCPMC11993856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.